MENU
NKTR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nektar Therapeutics (NKTR) Ownership - Who owns Nektar Therapeutics?
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
111.76M
P/E Ratio
N/A
Total Cash
244.5M
Projected Growth
N/A
Total Debt
108.26M
Revenue
93.14M
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price
Fundamentals
NKTR
Capitalization
112M
P/E Ratio
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
244M
Total Cash/Share
1.31
Total Debt
108M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
93.1M
ROE
N/A
Book Value
48.9M
P/B Ratio
2.02
Cash Flow
N/A
Earnings
-0.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
4.24
Current Revenue Per Employee
176087.60
Dividends Per Share - Security
N/A
EBITDA
-137.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.62
Revenue To Assets
-44.87
Shares Held By Institutions
147M
Shares Outstanding - Current
186M
Total Liabilities
259M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-35.430
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of inhalation drug delivery systems
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com